Home » Topics » Disease categories and therapies » Immune

Immune
RSS

KRX-211 has potential in septic shock

June 3, 2002

FDA advisory committee supports efficacy of Prevnar in otitis media

May 23, 2002

Avant's cholera vaccine enters phase II study

May 22, 2002

Crucell and NIAID to develop Ebola vaccine

May 21, 2002

Bio-Vant TB vaccine induces antibody responses in mouse model

May 21, 2002

Isotechnika and Roche focus ISAtx-247 development on transplantation

May 14, 2002

Wyeth announces corrections to sirolimus prescribing information

May 14, 2002

Quilimmune-P stimulates high immune response in elderly subjects

May 13, 2002

New data on everolimus presented at the 2002 American Transplant Congress

May 6, 2002

TNX-901 increases symptom threshold to peanuts in phase II allergy study

May 3, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....